Tiansong Xia
Overview
Explore the profile of Tiansong Xia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
1036
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu Y, Xue N, Liu Y, Mei J, Cai Y, Wang Z, et al.
Transl Oncol
. 2025 Mar;
54:102343.
PMID: 40068383
Background: The tumor stroma has been reported to be associated with worse prognosis in several solid tumors, but its prognostic value in breast cancer (BRCA) is still undefined. Methods: In...
2.
Li M, Liu Y, Han X, Li T, Zhang Z, Xue N, et al.
Breast Cancer (Dove Med Press)
. 2024 Nov;
16:761-768.
PMID: 39553239
Background: Aneuploid circulating endothelial cells (CECs) are an indicator in breast cancer (BC). Significant changes of aneuploid CECs occurred during neoadjuvant chemotherapy (NCT). This study aimed to explore the predictive...
3.
Li J, Peng S, Zou X, Geng X, Wang T, Zhu W, et al.
Cancer Pathog Ther
. 2024 Feb;
1(3):159-167.
PMID: 38327836
Background: MicroRNA (miRNA) and mRNA levels in matching specimens were used to identify miRNA-mRNA interactions. We aimed to integrate transcriptome, immunophenotype, methylation, mutation, and survival data analyses to examine the...
4.
Shao W, Shi H, Liu J, Zuo Y, Sun L, Xia T, et al.
IEEE Trans Med Imaging
. 2024 Feb;
43(6):2266-2278.
PMID: 38319755
With the remarkable success of digital histopathology and the deep learning technology, many whole-slide pathological images (WSIs) based deep learning models are designed to help pathologists diagnose human cancers. Recently,...
5.
Mei J, Cai Y, Chen L, Wu Y, Liu J, Qian Z, et al.
Br J Cancer
. 2023 Sep;
129(10):1645-1657.
PMID: 37715025
Background: It has been acknowledged that the tumour immune microenvironment (TIME) plays a critical role in determining therapeutic responses and clinical outcomes in breast cancer (BrCa). Thus, the identification of...
6.
Sun H, Zhang L, Wang Z, Gu D, Zhu M, Cai Y, et al.
Nat Commun
. 2023 Sep;
14(1):5590.
PMID: 37696831
Male breast cancer (MBC) is a rare but aggressive malignancy with cellular and immunological characteristics that remain unclear. Here, we perform transcriptomic analysis for 111,038 single cells from tumor tissues...
7.
Liang M, Zhang Z, Zhang C, Chen R, Xiao Y, Li Z, et al.
Int J Hyperthermia
. 2023 Aug;
40(1):2240548.
PMID: 37544652
Objective: This nonrandomized prospective clinical trial aimed to assess the efficacy, safety and follow-up outcomes of ultrasound-guided high-intensity focused ultrasound (USgHIFU) surgery in patients with breast fibroadenoma. Methods: With the...
8.
Ma G, Wang J, Fu J, Chen R, Liang M, Li M, et al.
Breast Cancer Res Treat
. 2023 Jun;
201(1):27-41.
PMID: 37311933
Neoadjuvant chemotherapy (NCT) is the standard treatment for patients with locally advanced breast cancer (LABC). The predictive value of heterogeneous circulating tumor cells (CTCs) in NCT response has not been...
9.
Fu J, Chen R, Zhang Z, Zhao J, Xia T
Oncol Res
. 2023 Jun;
31(2):157-167.
PMID: 37304237
Background: Breast cancer has become the most common malignant tumor in the world. It is vital to discover novel prognostic biomarkers despite the fact that the majority of breast cancer...
10.
Wang Q, Yang H, Liu Y, Zhou Z, Zhang X, Sang M, et al.
Adv Healthc Mater
. 2023 May;
12(23):e2300420.
PMID: 37141500
Mast cells (MCs), powerful immune cells that heavily infiltrate cancer cells, play a crucial role in tumor formation. Activated MCs can release histamine and a family of proteases through degranulation...